RZ-004

N/A

Report date: 2026/05/13 09:17:13

Base Information

Drug NameRZ-004

Drug Alias NameRZ-004

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vectorSmall molecules > Nucleosides and nucleotide derivtives > Ribozyme

Mechanisms of ActionRHO gene transference

TargetsRhodopsin

Therapy Area/IndicationsRetinitis Pigmentosa

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesRznomics Inc

China Registration ClassN/A

Develop Information

Active CompaniesRznomics Inc

Inactive CompaniesN/A

Active IndicationsRetinitis Pigmentosa

Inactive IndicationsN/A

Other Information

ATC CodeN/A